High‐throughput cassette assay for drug stability measurement in plasma using direct HPLC‐MS/MS

Issue title: First International Conference on Biomedical Spectroscopy: From molecules to men, Cardiff, UK, 7–10 July 2002, Part II

Article type: Research Article

Authors: Wang, Gangfeng | Hsieh, Yunsheng | Cheng, K.‐C. | Ng, Kwokei | Korfmacher, Walter A.

Affiliations: Drug Metabolism and Pharmacokinetics Department, Schering Plough Research Institute, 2015 Galloping Hill Road, K‐15‐3700, Kenilworth, NJ 07033, USA

Note: [] Corresponding author. Tel: +1 908 740 585; E‐mail: yunsheng.hsieh@spcorp.com.

Abstract: A high‐throughput semi‐automated procedure for simultaneously stability evaluation of multiple compounds in plasma using direct single column high‐performance liquid chromatography (HPLC) combined with tandem mass spectrometry (MS/MS) was developed to eliminate the laborious procedures that are traditionally used for stability studies. Untreated human, monkey, mouse and rat plasma samples containing ten drug components were directly injected into a mixed‐functional column that provided both protein removal and chromatographic functionality. Ten test compounds were simultaneously assayed using a tandem mass spectrometer in the positive ion mode using multiple reaction monitoring (MRM). Plasma samples containing ten test compounds were placed in a thermostatic autosampler and then sequentially monitored in one analytical procedure. The time between each injection was set about 7 minutes. The peak responses of the test compounds in individual plasma samples were repeatedly determined every 28 minutes. Drug stability in plasma was indicated by the change of the mass chromatographic peak areas for the test compounds and was observed to be a function of animal species, incubation time and incubation temperature. The potential for matrix ionization suppression on the direct single column HPLC‐MS/MS system was also investigated using the post‐column infusion technique. The proposed cassette assay procedure provides an analytical throughput ten times greater than the single component approach for the evaluation of drug stability in plasma without compromising data quality.

Journal: Spectroscopy, vol. 17, no. 2-3, pp. 511-519, 2003